iBio Company
iBio is a technology platform that develops pharmaceutical product applications
Technology:
COVID
Industry:
Small&Large Molecules
Headquarters:
Newark, Delaware, United States
Founded Date:
2008
Employees Number:
1-10
Funding Status:
N/A
Total Funding:
12265000
Estimated Revenue:
Less than $1M
Last Funding Date:
2016
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership